Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by UniverseofLimeson Oct 30, 2018 9:15am
97 Views
Post# 28893171

RE:RE:RE:Big Picture

RE:RE:RE:Big PictureAgain, I politely disagree. The multinational corps do their dd prior to throwing around money unlike some of the retail investors which at the moment are the majority of the sector. As for Canopy, honestly, do you expect Canopy to be profitable last quarter when cannabis was not even decrimanized? If you are wanting to gauge some numbers you will have to wait for the numbers for oct/nov/Dec, but even those will be slightly off due to the way the provincial governments have executed their part of the decriminalization of cannabis.
Bitofgreen wrote: Hopefully, with the investment, Canopy can turn the 100M loss they posted last quarter into profit. Increasing any stock price artificially only supports the current environment. 


UniverseofLimes wrote: Politely disagree, an inked deal with a multinational Corp with big pockets would increase the sp immediately and allow Apha to invest globally in order to achieve future growth. The market will not reward a company with moderate numbers in the Canadian space alone anymore. We know apha's game plan and we need some home run hits to ignite the sector. If you recall what constellations did for the sector and the dramatic impact to the sector and to Canopy as well.
Bitofgreen wrote: Bottom line is the only metric that matters. Listing, partners and hoping for news does not replace revenues, governance and profit. To achieve the latter, growth is required. The market will react when this is demonstrated and until then expect volatility.  If you believe in the company, buy when you can, accumulate and shut out the noise. 






Bullboard Posts